Drug-related problem in children with chronic kidney disease

Pediatric Nephrology

Volumn 28, Issue 1, 2013, Pages 25-31

  Ibrahim, Norkasihan ^a   Wong, Ian Ck ^a,b   Patey, Susan ^c   Tomlin, Stephen ^d   Sinha, Manish D ^d   Jani, Yogini ^a,e  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Children; Chronic kidney disease; Drug therapy; Drug related problem; Epidemiology; Paediatrics; Pharmacotherapy

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; ADVERSE OUTCOME; CHILD; CHRONIC KIDNEY DISEASE; DRUG RELATED PROBLEM; DRUG SAFETY; HEALTH CARE COST; HEALTH STATUS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MEDICATION ERROR; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

CHILD; DRUG THERAPY; DRUG TOXICITY; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84870459441     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2149-1     Document Type: Review

References (34)

1. Lewis MA, Shaw J, Sinha MD, Adalat S, Hussain F, Castledine C, van Schalkwyk D, Inward C (2009) Demography of the UK paediatric renal replacement therapy population in 2008. In: 12th report of UK Renal Registry. Available at: http://www.renalreg.com/Report-Area/Report%202008/Chapter14.pdf. Accessed 27 Mar 2011
2. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2010) United States Renal Data System, USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Available at: http://www.usrds.org/atlas.htm. Accessed 27 Mar 2011
3. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2011) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363-373
4. Warady BA, Chadha V (2007) Chronic kidney disease in children: the global perspective. Pediatr Nephrol 22:1999-2009
5. Kaplan B, Mason NA, Shimp LA, Ascione FJ (1994) Chronic hemodialysis patients. Part I: characterization and drug-related problems. Ann Pharmacother 28:316-319
6. Manley HJ, Drayer DK, Muther RS (2003) Medication-related problem type and appearance rate in ambulatory hemodialysis patients. BMC Nephrol 4:1-7
7. Cardone KE, Bacchus S, Assimon MM, Pai AB, Manley HJ (2010) Medication-related problems in CKD. Adv Chronic Kidney Dis 17:404-412
8. Grabe DW, Low CL, Bailie GR, Eisele G (1997) Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 47:117-121
9. Kaplan B, Mason NA, Shimp LA, Ascione FJ (1994) Chronic hemodialysis patients. Part II: reducing drug-related problems through application of the focused drug therapy review program. Ann Pharmacother 28:320-324
10. Tozawa M, Iseki K, Iseki C, Oshiro S, Higashiuesato Y, Yamazato M, Tomiyama N, Tana T, Takishita S (2002) Analysis of drug prescription in chronic haemodialysis patients. Nephrol Dial Transplant 17:1819-1824
11. Mirkov S (2009) Implementation of a pharmacist medication review clinic for haemodialysis patients. N Z Med J 122:25-37
12. Sathvik BS, Mangasuli S, Narahari MG, Gurudev KC, Parthasarathi G (2007) Medication knowledge of hemodialysis patients and influence of clinical pharmacist provided education on their knowledge. Indian J Pharm Sci 69:232-239
13. Pai AB, Boyd A, Chavez A, Manley HJ (2009) Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomized, controlled study. Hemodial Int 13:72-79
14. Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H (2009) Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy 29:1433-1440
15. Manley HJ, Carroll CA (2002) The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 15:45-49
16. Pharmaceutical Care Network Europe (2010) Classification for drug-related problems: version 6.2 (14-10-2010)'. Available at: http://www.pcne.org/sig/drp/ documents/drp/PCNE%20classification%20V6-2.pdf. Accessed 7 April 2011
17. Frommer M, Rubin G, Lyle D (1992) The NSW health outcomes program. N S W Public Health Bull 3:135
18. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD (1990) Drug-related problems: their structure and function. Drug Intel Clin Pharm 24:1093-1097
19. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H (1991) The nature of adverse events in hospitalized patients. Results of the Harvard medical practice study II. N Engl J Med 324:377-384
20. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255-1259
21. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW (2004) Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 13:306-314
22. So TY, Layton JB, Bozik K, Farrington E, Gipson PE, Gibson K, Primack W, Conley W 3rd, Gipson DS, Ferris M (2011) Cognitive pharmacy services at a pediatric nephrology and hypertension clinic. Renal Fail 33:19-25
23. Jani YH, Ghaleb MA, Marks SD, Cope J, Barber N, Wong IC (2008) Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic. J Pediatr 152:214-218
24. Perrier-Cornet E, Prot-Labarthe S, Bourdon O, Brion F (2010) Report of pharmaceutical care in a nephrology paediatric care unit. Pharm World Sci 32:259-259
25. Lincenberg J, Lerner G, Robin A, Layfield S, Macdonald N, Fleischmann L, Gruskin A (1986) Improving compliance in adolescent CAPD patients. Am J Kidney Dis 8:A13-A13
26. Atiyeh BA, Dabbagh SS, Gruskin AB (1996) Evaluation of renal function during childhood. Pediatr Rev 17:175-180
27. Brandt JR, Wong CS, Hanrahan JD, Qualls C, McAfee N, Watkins SL (2006) Estimating absolute glomerular filtration rate in children. Pediatr Nephrol 21:1865-1872
28. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS (2003) National kidney foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416-1421
29. Kimland E, Bergman U, Lindemalm S, Böttiger Y (2007) Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr 166:527-532
30. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77-83
31. Churchwell MD, Mueller BA (2007) Selected pharmacokinetic issues in patients with chronic kidney disease. Blood Purif 25:133-138
32. Chisholm-Burns MA, Spivey CA, Rehfeld R, Zawaideh M, Roe DJ, Gruessner R (2009) Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant 9:2497-2504
33. Chisolm MA, Kwong WJ, Spivey CA (2007) Associations of characteristics of renal transplant recipients with clinician's perceptions of adherence to immunosuppressant therapy. Transplantation 84:1145-1150
34. El Nahas M (2005) The global challenge of chronic kidney disease. Kidney Int 68:2918-2929